GT Biopharma (GTBP) had the highest return between 2010 and 2012 by a US stock in the Nasdaq Composite (IXIC), returning 338,299,730%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2010-2012	338,299,730%
NextTrip (NTRP)	2010-2012	38,566.67%
INVO Fertility (IVF)	2010-2012	18,089.48%
Versus Systems Inc. (VS)	2010-2012	1,980%
BOS Better Online Solutions (BOSC)	2010-2012	1,458.94%
Netcapital (NCPL)	2010-2012	1,300%
N2OFF (NITO)	2010-2012	1,150%
VirnetX Holding Corp Common Stock (VHC)	2010-2012	957.2%
Sunshine Biopharma (SBFM)	2010-2012	941.67%
BTCS (BTCS)	2010-2012	760%
Intelligent Protection Management (IPM)	2010-2012	733.33%
Lifevantage (LFVN)	2010-2012	711.14%
Barfresh Food (BRFH)	2010-2012	670%
BioRestorative Therapies (BRTX)	2010-2012	669.23%
Red Cat (RCAT)	2010-2012	650%
Paysign (PAYS)	2010-2012	642.5%
Heritage Global (HGBL)	2010-2012	633.33%
Natural Health Trend (NHTC)	2010-2012	621.38%
Astrana Health (ASTH)	2010-2012	614.29%
Regeneron Pharmaceuticals (REGN)	2010-2012	605.73%
Where Food Comes From (WFCF)	2010-2012	600.01%
Neonode (NEON)	2010-2012	594.29%
Jazz Pharmaceuticals (JAZZ)	2010-2012	560.67%
Provident Financial (PROV)	2010-2012	555.11%
XTL Biopharmaceuticals Ltd ADR (XTLB)	2010-2012	547.57%